Aerocrine Launches a New Fully Portable Hand-Held Device to Measure Airway Inflammation in Asthma
9/11/2013 9:39:21 AM
SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AERO-B)(OMX Nordic Exchange: AERO) is pleased to announce the launch of NIOX VERO®, a new, fully portable hand-held point-of-care device for the measurement of airway inflammation, such as asthma. Aerocrine introduces the new device in conjunction with the European Respiratory Society (ERS) annual meeting in Barcelona, September 7-11, 2013. NIOX VERO® was developed in collaboration between Aerocrine and Panasonic Healthcare Co.,Ltd.
Help employers find you! Check out all the jobs and post your resume.
comments powered by